Suven Pharmaceuticals informs about press release

26 Dec 2022 Evaluate

Suven Pharmaceuticals has informed that the Board of Directors of the Company have been informed by its Promoter, Jasti Property and Equity Holdings (in its capacity as sole trustee of Jasti Family Trust), that they have executed a Share Purchase Agreement with Berhyanda, a Cyprus based company on December 26, 2022. The company has attached Press Release of the acquirer. This intimation is also being uploaded on the Company’s website at www.suvenpharm.com.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

535.10 -0.65 (-0.12%)
26-Dec-2025 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.10
Dr. Reddys Lab 1266.60
Cipla 1506.15
Zydus Lifesciences 910.75
Lupin 2112.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×